Skip to main content

Table 1 Baseline Characteristics of Patients and Home Nebulizers

From: Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations

Data regarding patients/ home nebulizersMean ± SD or n (%)
Total = 61
Age (years)7.6 ± 4.2
Weight (Kg)23.6 ± 13.3
Height / length (cm)121.3 ± 25.3
Male gender (%)35 (57.4%)
Type of home nebulizers (%)
 Jet39 (63.9%)
 Ultrasonic16 (26.2%)
 Mesh6 (9.8%)
Duration of use (years)3.6 ± 2.9
Replace nebulizer parts
 None48 (78.5%)
 Mask/mouthpiece6 (10%)
 Reservoir4 (6.5%)
 Connecting tube3 (5%)
Number of daily inhalation
 All devices2.6 ± 0.7
 Contaminated devices2.7 ± 0.7
 Clean devices2.3 ± 0.8
Inhaled antibiotics (%)
 None23 (37.7%)
 Gentamicin18 (29.5%)
 Amikacin10 (16.4%)
 Tobramycin2 (3.3%)
 Vancomycin8 (13.1%)